Skip to main content

Blood transfusion is an independent predicting factor for poor outcome after cardiac surgery

Introduction

Blood transfusion is associated with worse outcome in critically ill patients. A restrictive strategy of blood transfusion has been advocated in patients undergoing cardiac surgery in order to avoid clinical complications related to exposure to blood components. Nevertheless, the blood transfusion rate remains elevated in clinical practice.

Methods

We performed a retrospective study with 750 patients undergoing elective coronary arterial graft bypass (CABG) surgery, valvar surgery or combined procedure under cardiopulmonary bypass (CPB) between October 2010 and October 2011 at a university hospital cardiac surgery referral center in Brazil. We collected baseline characteristics and preoperative laboratory data, EuroSCORE, type of surgical procedure, intraoperative characteristics, blood transfusion exposure, postoperative severe complication as bleeding, low output cardiac syndrome, vasoplegia syndrome, myocardial ischemia, stroke, ventricular or supraventricular tachyarrhythmia, respiratory failure, acute renal failure, infection, ICU length of stay, hospital length of stay and mortality in 30 days.

Results

A total of 512 patients (68.4%) was exposed to blood transfusion components. Transfused patients presented a higher number of severe clinical complications in the postoperative period compared to nontransfused patients (74 (34.1%) vs. 312 (61.9%), P < 0.0001). Also, the mortality rate was higher in transfused patients than nontransfused patients (1 (0.5%) vs. 18 (3.6%), P < 0.016). In a multivariate analysis, age, obesity, perioperative myocardial ischemia, valve disease, heart failure, blood transfusion and CPB duration are independently associated with mortality.

Conclusion

Blood component exposure is associated with poor outcome and mortality in patients undergoing cardiac surgery. Despite the evidence that blood transfusion is associated with worse outcome, the blood transfusion rates remain unacceptably high in clinical practice.

References

  1. 1.

    Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al.: Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010, 304: 1559-1567. 10.1001/jama.2010.1446

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to J Almeida.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Almeida, J., Zeferino, S., Galas, F. et al. Blood transfusion is an independent predicting factor for poor outcome after cardiac surgery. Crit Care 16, P442 (2012). https://doi.org/10.1186/cc11049

Download citation

Keywords

  • Blood Transfusion
  • Transfuse Patient
  • Supraventricular Tachyarrhythmia
  • Cardiac Syndrome
  • Postoperative Severe Complication